Michael Hawley

500 total citations
15 papers, 391 citations indexed

About

Michael Hawley is a scholar working on Materials Chemistry, Pharmaceutical Science and Condensed Matter Physics. According to data from OpenAlex, Michael Hawley has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Materials Chemistry, 6 papers in Pharmaceutical Science and 3 papers in Condensed Matter Physics. Recurrent topics in Michael Hawley's work include Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (6 papers) and Physics of Superconductivity and Magnetism (3 papers). Michael Hawley is often cited by papers focused on Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (6 papers) and Physics of Superconductivity and Magnetism (3 papers). Michael Hawley collaborates with scholars based in United States, Germany and Switzerland. Michael Hawley's co-authors include David C. Sperry, W. Morozowich, Guang Wei Lu, William P. Pfund, Mark E. Smith, Brenda M. Geiger, Gregory E. Amidon, Changquan Calvin Sun, Chenguang Wang and X. D. Wu and has published in prestigious journals such as Applied Physics Letters, Journal of Pharmaceutical Sciences and Crystal Growth & Design.

In The Last Decade

Michael Hawley

15 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hawley United States 9 255 218 67 61 56 15 391
David C. Sperry United States 13 271 1.1× 168 0.8× 105 1.6× 64 1.0× 28 0.5× 25 476
Masatoshi Karashima Japan 11 147 0.6× 151 0.7× 51 0.8× 26 0.4× 99 1.8× 18 397
Yasushi Shono Japan 7 409 1.6× 171 0.8× 97 1.4× 95 1.6× 37 0.7× 7 576
Anna Akrami United States 5 291 1.1× 280 1.3× 85 1.3× 49 0.8× 138 2.5× 7 491
Yi‐Ling Hsieh Taiwan 8 158 0.6× 161 0.7× 101 1.5× 41 0.7× 18 0.3× 10 361
Wonkyung Cho South Korea 15 434 1.7× 273 1.3× 121 1.8× 79 1.3× 131 2.3× 23 744
Fernando Alvarez‐Núñez United States 13 333 1.3× 438 2.0× 164 2.4× 58 1.0× 244 4.4× 26 812
Christianah Moji Adeyeye United States 14 314 1.2× 89 0.4× 83 1.2× 76 1.2× 12 0.2× 24 460
Koji Shiraki Japan 6 203 0.8× 320 1.5× 62 0.9× 29 0.5× 261 4.7× 10 503
Madhu Pudipeddi United States 7 248 1.0× 312 1.4× 152 2.3× 56 0.9× 143 2.6× 8 568

Countries citing papers authored by Michael Hawley

Since Specialization
Citations

This map shows the geographic impact of Michael Hawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hawley more than expected).

Fields of papers citing papers by Michael Hawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hawley. The network helps show where Michael Hawley may publish in the future.

Co-authorship network of co-authors of Michael Hawley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hawley. A scholar is included among the top collaborators of Michael Hawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hawley. Michael Hawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xin, Dongyue, Kevin Briggs, Saurabh Gautam, et al.. (2025). Characterization of VSV-GP morphology by cryo-EM imaging and SEC-MALS. Molecular Therapy — Methods & Clinical Development. 33(1). 101429–101429. 2 indexed citations
2.
Aburub, Aktham, Yuan Chen, Ping Gao, et al.. (2022). An IQ Consortium Perspective on Connecting Dissolution Methods to In Vivo Performance: Analysis of an Industrial Database and Case Studies to Propose a Workflow. The AAPS Journal. 24(3). 49–49. 8 indexed citations
3.
Huang, Wenjun, Qinfang Zhang, Changquan Calvin Sun, et al.. (2022). Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance. Crystal Growth & Design. 22(9). 5154–5167. 9 indexed citations
4.
Waterman, Kenneth C., et al.. (2021). Stability screening of pharmaceutical cocrystals. Pharmaceutical Development and Technology. 26(10). 1130–1135. 4 indexed citations
5.
Wang, Chenguang, et al.. (2018). Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate. Journal of Pharmaceutical Sciences. 108(1). 516–524. 34 indexed citations
6.
Sperry, David C., et al.. (2010). Relative Bioavailability of Three Different Solid Forms of PNU-141659 as Determined with the Artificial Stomach-Duodenum Model. Journal of Pharmaceutical Sciences. 99(9). 3923–3930. 43 indexed citations
7.
Hawley, Michael & W. Morozowich. (2010). Modifying the Diffusion Layer of Soluble Salts of Poorly Soluble Basic Drugs To Improve Dissolution Performance. Molecular Pharmaceutics. 7(5). 1441–1449. 42 indexed citations
8.
Amidon, Gregory E., et al.. (2005). Application of Powder X-ray Diffraction in Studying the Compaction Behavior of Bulk Pharmaceutical Powders. Journal of Pharmaceutical Sciences. 94(11). 2520–2530. 34 indexed citations
9.
Sperry, David C., et al.. (2005). Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. Journal of Pharmaceutical Sciences. 95(1). 116–125. 103 indexed citations
10.
Lu, Guang Wei, Michael Hawley, Mark E. Smith, Brenda M. Geiger, & William P. Pfund. (2005). Characterization of a novel polymorphic form of celecoxib. Journal of Pharmaceutical Sciences. 95(2). 305–317. 86 indexed citations
11.
Cooke, D. W., Bryan Bennett, R. E. Muenchausen, et al.. (1997). <title>Pyroelectricity and its role in optical damage of potassium titanyl phosphate crystals</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2966. 41–47. 1 indexed citations
12.
Reagor, D., J. Decker, Y. Fan, et al.. (1997). Noise and Operational Characteristics of Magnetometers Made from Superconducting-Normal-Superconducting Josephson Junctions. MRS Proceedings. 474. 1 indexed citations
13.
Bergren, Michael S., P. A. MEULMAN, Ronald W. Sarver, et al.. (1996). Solid Phases of Delavirdine Mesylate. Journal of Pharmaceutical Sciences. 85(8). 834–841. 9 indexed citations
14.
Pluym, Tammy, R. E. Muenchausen, P. N. Arendt, et al.. (1995). Superconducting Tl/sub 2/Ba/sub 2/CaCu/sub 2/O/sub 8/ thin films prepared by post-annealing in a flow-through multiple-zone furnace. IEEE Transactions on Applied Superconductivity. 5(2). 1339–1342. 6 indexed citations
15.
Reagor, D., R. J. Houlton, Michael Hawley, et al.. (1995). Development of high temperature superconducting Josephson junctions and quantum interference devices using low deposition temperature YBa2Cu3O7−x barriers. Applied Physics Letters. 66(17). 2280–2282. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026